NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Beijing Geneplus Technology

Beijing Geneplus Technology

Private
Beijing, BeijingHealthcare & Life Scienceshttps://www.geneplus.cn/

Last Round

Series D

Nov 30, 2025

Est. Valuation

$597.22M

Total Funding Raised

$333.44M

Company Overview

Beijing Geneplus Technology is a biotechnology company that provides a range of services and products for cancer precision medicine based on next-generation sequencing (NGS) technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision oncologynext-generation sequencingNGSgenomic profilingliquid biopsycancer diagnosticsin vitro diagnosticsIVDgene sequencertumor bioinformaticsCRO servicescontract research organizationNGS data analysisautomated library preparation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing Geneplus Technology Comparables

Compare Beijing Geneplus Technology with similar companies based on industry and business-model similarity.

Beijing Geneplus Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genecast
91%
HaploX
89%
New Genetron Holding Limited
88%

Beijing Geneplus Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DNov 30, 2025
Series DDec 1, 2023
Series CJul 22, 2021
Series B ExtensionNov 16, 2020
Series BJul 31, 2019
Series B
Jul 1, 2019

Key People

Founding team and executive leadership

熊力

CFO

Executive Team

Beijing Geneplus Technology Investors

Notable investors and investment history

Beijing Geneplus Technology investors
InvestorRounds
Beijing Chang DevelopmentSeries D
Baidu VenturesSeries C
Chuanghehui CapitalSeries C
蔚亭资本Series C
Highlight CapitalSeries B Extension
Jiangsu Honghui Equity Investment ManagementSeries B Extension
Jiyuan CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 14, 2019

    $7.39M round led by BGI Group

Beijing Geneplus Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beijing Geneplus Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beijing Geneplus Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing, Beijing
Employee Range92
Year Founded2015
Last FundingNov 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.